The India Watch

Jubilant Co. is set to sell a $139 million interest in a US corporation

<p><strong>NEW DELHI:</strong> For $139.4 million, Jubilant Pharma, a division of Jubilant Pharmova, will sell its whole 25.8% ownership in Sofie Biosciences, a US company. According to a statement from the firm, Singapore-based Jubilant Pharma contributed $25 million to Sofie in November 2020.</p>
<p><img decoding=”async” class=”alignnone wp-image-382453″ src=”” alt=” jubilant co is set to sell a 139 million interest in a us corporation 107274025 1″ width=”1017″ height=”572″ title=”Jubilant Co. is set to sell a $139 million interest in a US corporation 15″ srcset=” 400w,×220.png 390w,×84.png 150w” sizes=”(max-width: 1017px) 100vw, 1017px” /></p>
<p>Sofie is a company that develops and provides molecular medicines and diagnostics (theranostics). It possesses an advanced contract manufacturing services network, a radiopharmaceutical production and distribution network, and valuable therapeutic intellectual property.<br />
It and several private equity groups have recently finalized their merger deal.</p>

Related posts

After the Ram Temple was dedicated, Ayodhya’s real estate prices skyrocketed: study

Nifty finishes over 19,800 and the Sensex climbs 393 points on higher energy and FMCG shares

Angel One is penalized by the NSE with a $1.67 million fine and is prohibited from adding new APs

Sensible guidelines for women in leadership

For the previous two years, 23 IT workers have been fired per hour

FPIs are increasing their debt instrument investments while decreasing their equity holdings